Clinical trial · Interventional
Diabetes Care for Breast Cancer Patients
Optimizing Delivery of Diabetes Management During Breast Cancer Care
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this study is to find a new way to make diabetes care better for patients with breast cancer and diabetes who are currently receiving cancer treatment. We will have two groups, the researchers will decide who is in which group. One group will be working with a nurse who is trained in diabetes care while the other does not. This will allow the investigators to see if having a trained nurse as part of the care team can help improve the care the patients receive.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| PreDiabetes | — | UNRESOLVED | — |
| Type 2 Diabetes | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Nurse-practitioner led intervention | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Nurse-practitioner led intervention group
- description
- A nurse practitioner (NP) who is trained in diabetes on the oncology team will help manage diabetes for breast cancer patients undergoing cancer treatments
- interventionNames
- Behavioral: Nurse-practitioner led intervention
- type
- NO_INTERVENTION
- label
- Non-intervention (control) group
- description
- Patient will not have access to the nurse practitioner led intervention.
Primary outcomes (8)
- measure
- Recruitment Success Ratio
- timeFrame
- 2 years
- description
- Number of participants recruited divided by the number of participants approached
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Newly diagnosed invasive cancer * Plan to receive neo-adjuvant or adjuvant chemotherapy, targeted therapy, hormonal therapy, or radiation at Weill Cornell Medicine (WCM) * Age 18+ years * Pre-diabetes OR type 2 diabetes. Treatment with antidiabetic medication OR * HbA1c greater than or equal to 5.7 OR * Random glucose greater than or equal to OR * Fasting blood glucose greater than or equal to 100 Exclusion Criteria: * Patients receiving hospice care * Type 1 diabetes
References
Publications (2)
- BACKGROUNDGearing RE, El-Bassel N, Ghesquiere A, Baldwin S, Gillies J, Ngeow E. Major ingredients of fidelity: a review and scientific guide to improving quality of intervention research implementation. Clin Psychol Rev. 2011 Feb;31(1):79-88. doi: 10.1016/j.cpr.2010.09.007. Epub 2010 Oct 7. PMID 21130938
- BACKGROUNDGlasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999 Sep;89(9):1322-7. doi: 10.2105/ajph.89.9.1322. PMID 10474547